{
    "2018-10-12": [
        [
            {
                "time": "",
                "original_text": "贝达药业：以量补价效果继续显现 三季度利润增长出拐点",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "以量补价",
                        "三季度",
                        "利润增长",
                        "拐点"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "巨丰热点：抗肿瘤药物纳入医保目录 部分药业股呈现市场活跃",
                "features": {
                    "keywords": [
                        "巨丰热点",
                        "抗肿瘤药物",
                        "医保目录",
                        "药业股",
                        "市场活跃"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}